← FDA DRUG APPROVALS

FDA NDA · NDA214510

EPSOLAY

benzoyl peroxide

Sponsor: MAYNE PHARMA

APPLICATION
NDA214510
TYPE
NDA
ORIGINAL APPROVAL
2022-04-22
LATEST ACTION
2022-04-22
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

EPSOLAY · ReferencePrescription
BENZOYL PEROXIDE 5% · CREAM · TOPICAL

Approval history

2022-04-22UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →